Search Results
Results found for "Dopamine receptor D3"
- InĂȘs Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem
As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
explore the development of powerful multiplex tools designed to map GPCR-RAMP interactions across the receptor That curiosity laid the foundation for a broader investigation into receptor activity-modifying proteins The labâs early partnership with students like Emily Lorenzen catalyzed a transition from single-receptor From Many to One: De-Orphanization and Precision Focus âYou can use this system to de-orphanize receptors Instead of focusing on a single receptor, students now gravitate toward platforms , biosensors , and
- Exploring Career Paths in GPCR Research with Dr. Jacek MokrosiĆski | Dr. GPCR Ecosystem
and worked closely with Dr Birgitte Holst studying structural and mechanistic properties of ghrelin receptor associated with obesity and other metabolic diseases, including GPR10, Melanocortin 4, Serotonin 2C and TRH receptors cell-based in vitro technologies to study mechanistic properties of GPCRs and understanding the dynamics of receptor Jacek shared his fascination with the growth hormone secretion receptor and the melanocortin 4 receptor Yamina, in turn, talked about her work on melanocortin receptors and an upcoming collaboration with a
- Nicole Perry-Hauser | Dr. GPCR Ecosystem
endeavoring to build a productive, independent scientific research career in adhesion G protein-coupled receptor research interests involve resolving signaling pathways downstream of aGPCRs and establishing how/if these receptors
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
the early days of ion channel chemistry to pioneering peptideâfluorophore conjugates for the GLP-1 receptor Why targeting the pharmacologically relevant surface-exposed receptor pool changes the way scientists The moment when super-resolution imaging revealed nanoscale receptor domains that conventional tools lab integrates synthetic chemistry, theoretical chemistry, cell biology, and imaging to understand receptor
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
journey highlights the transition from general drug development to a deep dive into G protein-coupled receptors at the University of Michigan, Ben focuses on positive allosteric modulators (PAMs) targeting opioid receptors thiazolidines and xanthinediones, Ben is helping define how structurally different PAMs may act on similar receptor from the University of Minnesota in 2022, studying the pharmacokinetics and pharmacodynamics of NMDA receptor determining the mechanisms of action of a series of positive allosteric modulators of the mu-opioid receptor
- Dr. Gregory Tall | Dr. GPCR Ecosystem
peptide agonist mechanism that differed from the common example known at the time, protease activated receptors Adhesion GPCRs pre-cleave themselves and the two resultant fragments of the receptor remain together adhesion GPCRs in complex physiological contextsâŠone being our discovery that GPR56 is the platelet receptor
- Dr. Sudha Shenoy | Dr. GPCR Ecosystem
Shenoyâs postdoctoral research discovered that ubiquitination of mammalian G protein-coupled receptors for lysosomal degradation, whereas ubiquitination of the adaptor protein, ÎČ-arrestin, is a tag for receptor
- Dr. Shivani Sachdev | Dr. GPCR Ecosystem
Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid receptors
- Brendan Wilkins | Dr. GPCR Ecosystem
assistant at the Victor Chang Cardiac Research Institute where he investigated the orphan G protein-coupled receptor Brendan is now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the
- how-to-build-breakthrough-gpcr-programs | Dr. GPCR Ecosystem
His recent work on muscarinic acetylcholine receptor modulation and structure-guided design of M1 receptor
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
Hannes Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors
- Dylan Eiger | Dr. GPCR Ecosystem
focuses on the mechanisms underlying biased signaling at GPCRs, specifically, the role of differential receptor He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus
- GPCR Webinars | Dr. GPCR Ecosystem
Webinars Upcoming Live & On Demand Webinars Receptor Signaling Bias: A Valuable and Accessible Property Terry Kenakin - UNC Chappel Hill | Terry's Pharmacology Corner Topics Covered The biological basis of receptor GPCR webinars are free, live online scientific sessions focused on G protein-coupled receptor biology Whether you're deep in receptor biology or evaluating assay tools, these sessions are built for you. Every session is grounded in receptor biology with a focus on what's practical and applicable.
- Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem
, and a near-total absence of characterized ligands, these receptors long resisted the molecular tools The work connects receptor biology to neuropsychiatric disease: addiction, autism spectrum disorder, Scientific Themes of the Conversation Adhesion GPCRs as a distinct receptor class â autoproteolytic architecture disorder, schizophrenia, and cancer The structural bottleneck: what cryo-EM cannot yet capture about receptor What the field still cannot do is observe the dynamics of receptor assembly, complex formation, and signaling
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
his UC San Diego postdoc Krishna Sriram, he reread the literature on ACE inhibitors and angiotensin receptor His research career has centered on GPCR signaling â with particularly deep work on beta-adrenergic receptors , cyclic AMP regulation, and receptor biology across tissue systems. If the virus disrupts one arm of this receptor-peptide system, the therapeutic question stops being " Type II pneumocytes carry the highest beta-2 receptor density in the body.
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
Aurelien Rizk shared that he had always focused on GPCRs but had also worked on other types of receptors Yamina Berchiche had a detailed conversation about the intricacies of cell signaling and chemokine receptors They validated their technology and made collaborations for expertise on chemokine receptors. Therapeutic Effect and Receptor Interactions Aurelien Rizk and Yamina had a detailed discussion about They emphasized the need to quantify the dynamics of the pathways and the residence time of the receptor
- Dr. Mark Connor | Dr. GPCR Ecosystem
Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma receptors Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
developing a powerful new computational tool for identifying âsurrogateâ ligands (borrowed from other receptors this expertise to establish a research program that takes orphan GPCRs from âlockedâ, inaccessible receptors
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
đ This workshop will explore how different ligands (compounds) can stabilize unique receptor conformations , leading to distinct signaling outcomesâeven when binding to the same receptor. đ§Ź Receptor Flexibility : Ligands stabilize different receptor states, creating unique signaling pathways are Dynamic Players đč Different ligands trigger unique receptor states, meaning the same receptor can This allows for a side-by-side comparison of how different compounds influence receptor signaling. đ
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor at The Rockefeller University, where she studyâs the signaling and degradation of G protein-coupled receptors to understand the mechanism by which a new class of biased allosteric modulators for the neurotensin receptor
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
also went on to discover a âcounterion switchâ in visual pigments and to develop strategies to assay receptor-G-protein Many of the conceptual advances that stemmed from this work, such as the concept of âfunctional micro-domains â and the âhelix movement model of receptor activationâ were confirmed later when crystal structures , the parallel development of bioorthogonal labeling strategies to couple fluorophores to expressed receptors
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
and received my Ph.D. in Molecular Medicine in 2010 after studying the orphan atypical cannabinoid receptor I studied the function of RGS5, calcium-sensing receptor, and an orphan adhesion GPCR, GPR64/ADGRG2 in
- Dr. Timo De Groof | Dr. GPCR Ecosystem
within the research group and used this platform to develop nanobodies targeting viral G protein-coupled receptors with a special focus on the human cytomegalovirus-encoded chemokine receptor US28.
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
sedative that prolongs exhalation and induces bradycardiaâacting through alpha-2 adrenergic, not opioid, receptors investigates how fentanyl and xylazine shut down breathing through different mechanismsâwork that blends receptor Listen now and see how one scientist is turning molecules into a mission, bridging the gap between receptor
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
The same library has produced antibodies against orphan GPCRs and receptors without peptide ligands, bivalent IgG, the team hands functional biology teams a molecule that is ready for flow cytometry and receptor Receptors within a family share sequence and surface topography, so an antibody recovered against one 09:17 Why antibodies to GPCRs have stayed so intractable 09:29 The motif-directed library â encoding receptor motifs into CDR3 12:34 Why one antibody can open up a whole receptor family 14:36 Eight to ten weeks
- Dr. GPCR Board | Dr. GPCR Ecosystem
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over




























